DXCM DexCom, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

DXCM [NASD]

DexCom, Inc.

Healthcare | Diagnostics & Research | USA

statements

Index	S&P 500	P/E	184.15	EPS (ttm)	2.19	Insider Own	0.60%	Shs Outstand	95.74M	Perf Week	3.35%
Market Cap	38.22B	Forward P/E	123.80	EPS next Y	3.25	Insider Trans	-27.19%	Shs Float	95.14M	Perf Month	-5.48%
Income	204.70M	PEG	3.33	EPS next Q	0.64	Inst Own	97.70%	Short Float	4.05%	Perf Quarter	5.04%
Sales	1.72B	P/S	22.27	EPS this Y	175.80%	Inst Trans	1.07%	Short Ratio	4.43	Perf Half Y	53.01%
Book/sh	14.43	P/B	27.88	EPS next Y	18.70%	ROA	7.80%	Target Price	475.06	Perf Year	168.44%
Cash/sh	26.41	P/C	15.23	EPS next 5Y	55.35%	ROE	20.80%	52W Range	145.23 - 456.23	Perf YTD	83.94%
Dividend	-	P/FCF	182.85	EPS past 5Y	41.50%	ROI	7.10%	52W High	-11.81%	Beta	0.81
Dividend %	-	Quick Ratio	7.20	Sales past 5Y	41.60%	Gross Margin	64.90%	52W Low	177.05%	ATR	17.13
Employees	3900	Current Ratio	7.60	Sales Q/Q	34.30%	Oper. Margin	14.80%	RSI (14)	49.47	Volatility	4.27% 4.68%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	514.10%	Profit Margin	11.90%	Rel Volume	0.81	Prev Close	382.03
Shortable	Yes	LT Debt/Eq	1.24	Earnings	Jul 28 AMC	Payout	0.00%	Avg Volume	870.34K	Price	402.36
Recom	1.60	SMA20	0.13%	SMA50	-3.86%	SMA200	21.35%	Volume	707,501	Change	5.32%

May-27-20

Reiterated

Piper Sandler

Overweight

$375 → $450

May-14-20

Initiated

Wells Fargo

Equal Weight

$420

Mar-05-20

Initiated

Citigroup

Buy

$330

Nov-07-19

Upgrade

Guggenheim

Neutral → Buy

Nov-07-19

Reiterated

Canaccord Genuity

Buy

$185 → $195

Oct-23-19

Initiated

Stifel

Buy

Nov-28-18

Initiated

UBS

Neutral

$135

Oct-19-18

Upgrade

Goldman

Sell → Neutral

Sep-12-18

Upgrade

Northland Capital

Under Perform → Market Perform

Aug-02-18

Reiterated

Canaccord Genuity

Buy

$105 → $125

Jul-02-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-08-18

Upgrade

JP Morgan

Neutral → Overweight

May-11-18

Initiated

BofA/Merrill

Buy

$100

May-03-18

Reiterated

Canaccord Genuity

Buy

$81 → $85

Apr-04-18

Initiated

Guggenheim

Neutral

Apr-04-18

Initiated

Goldman

Sell

$57

Mar-23-18

Upgrade

Robert W. Baird

Neutral → Outperform

Jan-04-18

Downgrade

Northland Capital

Market Perform → Under Perform

Sep-28-17

Reiterated

Wedbush

Outperform

$85 → $76

Sep-28-17

Downgrade

Raymond James

Outperform → Mkt Perform

Sep-24-20 02:49PM	Dexcom and University of Virginia to Advance Diabetes Research Together Motley Fool
08:30AM	Dexcom Signs Multi-Year Collaboration Agreement with the University of Virginia to Advance Type 1 and Type 2 Diabetes Research Business Wire
06:23AM	3 Solid Stocks to Get You Through a Market Crash Motley Fool
Sep-22-20 08:51AM	4 Best Diabetes Device Stocks to Focus on Amid Coronavirus Crisis Zacks
08:30AM	Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States Business Wire
Sep-18-20 05:45PM	DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
09:07AM	DexCom Introduces Registry to Monitor Outcomes of G6 System Zacks
08:00AM	Do You Own The 10 Most Expensive Stocks Right Now? Investor's Business Daily
Sep-17-20 07:00AM	If You Invested $5,000 in Dexcom During the Coronavirus Market Crash, This Is How Much Money You'd Have Now Motley Fool
Sep-16-20 08:30AM	Dexcom Announces First-Ever Registry Dedicated to Tracking Outcomes of In-Hospital Real-Time CGM Use in Response to the COVID-19 Pandemic Business Wire
Sep-11-20 05:45PM	DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
Sep-10-20 05:51AM	3 Stocks for Robinhood Investors to Buy During a Stock Market Crash Motley Fool
Sep-04-20 12:08PM	Why DexCom, Livongo Health, and Teladoc Health Stocks Are Tumbling Today Motley Fool
09:36AM	Shareholders Are Raving About How The DexCom (NASDAQ:DXCM) Share Price Increased 479% Simply Wall St.
09:11AM	2 Healthcare Stocks You Should Buy, According to Wall Street Motley Fool
08:45AM	Dexcom Announces Upcoming Virtual Conference Presentations Business Wire
07:00AM	Top Mutual Fund Manager Likens Amazon To The 'Evil Empire' Investor's Business Daily
Sep-02-20 03:35PM	Dow, S&P 500 Spearhead Gains; These Growth Stocks Still Lead Investor's Business Daily +6.04%
03:15PM	Why DexCom Stock Jumped Today Motley Fool
10:57AM	Dexcom Springs To Life After Flat Action Investor's Business Daily Video
Aug-31-20 02:13PM	DexCom, Inc. (DXCM): Hedge Funds Taking Some Chips Off The Table Insider Monkey
Aug-27-20 11:31AM	DexCom (DXCM) Down 0.3% Since Last Earnings Report: Can It Rebound? Zacks
07:24AM	These 5 Stocks Are The Biggest S&P 500 Healthcare Winners of 2020 Motley Fool
Aug-26-20 03:28PM	Top Stocks for September 2020 Investopedia
01:27PM	Nevro Earns Relative Strength Rating Upgrade; Hits Key Benchmark Investor's Business Daily
Aug-24-20 01:12PM	Top Health Care Stocks for September 2020 Investopedia
Aug-22-20 01:52PM	The Smart Way To Profit Off The Internet Of Things Insider Monkey
Aug-20-20 04:59PM	How Has DexCom Stock Performed in 2020 So Far? Motley Fool
Aug-14-20 04:22PM	Dow Jones Drifts Higher; Three Leaderboard Stocks In Buy Zones Investor's Business Daily
Aug-13-20 05:11AM	3 Top Diabetes Stocks to Buy in August Motley Fool
Aug-12-20 08:30AM	Dexcom Appoints Karen Dahut to Board of Directors Business Wire
Aug-10-20 04:05PM	Dexcom Announces Upcoming Conference Presentation Business Wire
Aug-07-20 10:45AM	10 Best-Performing Stocks in Nasdaq ETF as Index Tops 11,000 Zacks
Aug-05-20 11:30AM	Target This Medical Device Stock in August Schaeffer's Investment Research
Aug-04-20 05:46PM	Stock Upgrades: Varian Medical Systems Shows Rising Relative Strength Investor's Business Daily
Aug-03-20 05:51AM	3 Stocks Robinhood Investors Should Buy With $1,000 Motley Fool
Jul-31-20 11:35AM	Dow Jones Down As Caterpillar, Microsoft, Chevron Pace Downside; Will A New Buy Point In Dexcom Emerge? Investor's Business Daily
08:00AM	How Top Fund Managers Spot Tomorrow's Stock Winners Early Investor's Business Daily
Jul-30-20 08:12AM	DexCom Looks Poised to Correct or Pull Back on Weakening Momentum TheStreet.com
07:42AM	DexCom, Inc. Just Beat EPS By 76%: Here's What Analysts Think Will Happen Next Simply Wall St.
Jul-29-20 09:40AM	DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates Zacks
06:55AM	Does DexCom (NASDAQ:DXCM) Have A Healthy Balance Sheet? Simply Wall St.
06:03AM	How DexCom More Than Doubled Wall Street's Q2 Earnings Estimate Motley Fool
01:31AM	Dexcom Inc (DXCM) Q2 2020 Earnings Call Transcript Motley Fool
Jul-28-20 05:45PM	DexCom (DXCM) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:55PM	Dexcom Stock Up, Masimo Stock Slips On Medtech Earnings Beats Investor's Business Daily
04:42PM	Recap: DexCom Q2 Earnings Benzinga
04:03PM	Dexcom Reports Second Quarter 2020 Financial Results Business Wire
08:19AM	Dow Jones Futures Signal Stock Market Rally Retreat Amid Earnings Rush; GOP Stimulus Plan Unveiled, Pfizer Vaccine Starts Phase 3 Trial Investor's Business Daily
Jul-27-20 08:31AM	Why DexCom (DXCM) Might Surprise This Earnings Season Zacks
Jul-26-20 07:21AM	4 Must-Own Recession Stocks Motley Fool
Jul-24-20 09:26AM	DexCom (DXCM) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-23-20 05:45PM	DexCom (DXCM) Dips More Than Broader Markets: What You Should Know Zacks
Jul-22-20 12:47PM	DexCom (DXCM) Likely To Remain Resilient From COVID-19 Impact Insider Monkey
Jul-21-20 12:31PM	DexCom (DXCM) Earnings Expected to Grow: Should You Buy? Zacks
08:18AM	Here's Why You Should Retain DexCom (DXCM) Stock For Now Zacks
Jul-19-20 07:32AM	Could DexCom Be a Millionaire-Maker Stock? Motley Fool
Jul-16-20 05:50PM	DexCom (DXCM) Dips More Than Broader Markets: What You Should Know Zacks
10:18AM	Health Canada Authorizes Interim Use of Dexcom G6 CGM by Pregnant Women in Response to the COVID-19 Pandemic CNW Group
07:19AM	Is Dexcom Stock a Buy? Motley Fool
Jul-15-20 05:00AM	A Stay-at-Home Stock Market Kept Investors Afloat Bloomberg
Jul-13-20 04:58PM	Nasdaq Sinks 227 Points as Zoom, Other Investor Favorites Reverse and Fall Hard Motley Fool -8.05%
Jul-10-20 05:45PM	DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
Jul-08-20 03:21PM	Were Hedge Funds Right About Piling Into DexCom, Inc. (DXCM)? Insider Monkey
Jul-07-20 08:11AM	Dow Jones Futures Fall After Apple, Amazon, Tesla, Microsoft Lead Coronavirus Stock Market Rally; Alibaba, Dexcom, Chipotle Break Out Investor's Business Daily
Jul-06-20 11:17AM	Dexcom Clears Buy Point Investor's Business Daily Video
08:48AM	The 3 Best S&P 500 Stocks So Far in 2020 Motley Fool
Jul-01-20 03:15PM	Dow Jones' Strength Wavers Due To Recent Rise In Coronavirus Cases; Growth Stocks Lead Market Investor's Business Daily
12:10PM	Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report? Zacks
07:28AM	If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now Motley Fool
Jun-30-20 05:50PM	DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know Zacks
08:45AM	Dexcom Schedules Second Quarter 2020 Earnings Release and Conference Call for July 28, 2020 at 4:30 p.m. Eastern Time Business Wire
Jun-26-20 08:23AM	Dow Jones Futures: Coronavirus Stock Market Rally Resilient As Tesla Leads Bullish Rebounds; Nike, JPMorgan, Goldman Move Late Investor's Business Daily
Jun-24-20 06:00AM	How This Bond Fund Has Beaten the Stock Market Over 25 Years Barrons.com
Jun-19-20 11:55AM	The Zacks Analyst Blog Highlights: Tesla, Fortinet, West Pharmaceutical Services, DexCom and Tractor Supply Zacks
Jun-18-20 07:43AM	Here's Why You Should Retain Glaukos in Your Portfolio Now Zacks
07:21AM	5 Best Stocks From 100 Days of Coronavirus Zacks
Jun-17-20 11:09AM	The Zacks Analyst Blog Highlights: Reckitt Benckiser, Henkel AG, DexCom, Tencent and Peloton Interactive Zacks
07:11AM	3 MedTech Stocks to Watch Amid Coronavirus Catastrophe Zacks
Jun-16-20 05:50PM	DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
08:10AM	Dow Jones Futures Jump, Extending Coronavirus Stock Market Rally; Tesla Back Above 1,000 Investor's Business Daily
Jun-15-20 05:18PM	Abbott Gains FDA Nod For A New Diabetes Device, But Dexcom Rockets Investor's Business Daily +7.70%
03:46PM	IBD 50 Stocks To Watch: Top Growth Stock Dexcom Surges After Key Hold Rule Expires Investor's Business Daily
10:35AM	Dexcom Keeps Finding Support Investor's Business Daily Video
10:25AM	Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle Motley Fool
Jun-12-20 08:58AM	3 Diabetes Management Stocks in the Spotlight Amid Coronavirus Zacks
Jun-10-20 06:59PM	Top-Performing Nasdaq Stocks So Far in 2020 GuruFocus.com
05:50PM	DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
08:19AM	DexCom's (DXCM) G6 CGM System Gets CE Marking in Europe Zacks
Jun-09-20 04:00AM	Dexcom G6 Continuous Glucose Monitoring (CGM) System Receives CE Marking in Europe for Wear on Back of the Upper Arm PR Newswire
Jun-08-20 04:33PM	IBD Stock Of The Day Dexcom Rebounds Into A New Buy Zone Here's Why Investor's Business Daily
09:32AM	ABIOMED Gets FDA Nod for First-in-Human Trial of Impella ECP Zacks
Jun-06-20 08:31AM	Here are the 10 most under and overbought S&P 500 stocks, according to Goldman MarketWatch
Jun-05-20 03:40PM	Dow Jones Soars 1,955 Points In 5 Days, Oil Jumps 5%; These 5 Top Stocks Break Out Investor's Business Daily +5.70%
10:42AM	Dexcom Rebounds Investor's Business Daily Video
09:48AM	Here's Why You Should Retain AmerisourceBergen Stock Now Zacks
08:15AM	Dow Jones Futures Lead Coronavirus Market Rally With Jobs Report In Focus; Tesla Back In 'Friend Zone,' Slack, RH Lead Earnings Movers Investor's Business Daily
Jun-04-20 05:00PM	Dow Jones Holds Up Better Than Nasdaq, Boeing Rockets Again; Sell Dexcom, Or Buy More? Investor's Business Daily -5.74%
09:00AM	Dexcom Announces Upcoming Conference Presentation Business Wire
Jun-03-20 03:13PM	Top Performers in the S&P 500 This Year Investopedia

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products; and a collaboration with Companion Medical, Inc. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 23	Sale	395.11	1,079	426,324	67,218	Sep 24 04:30 PM
AUGUSTINOS NICHOLAS	Director	Sep 16	Sale	399.78	1,875	749,596	13,842	Sep 18 04:57 PM
ALTMAN STEVEN R	Director	Sep 15	Sale	393.92	30,000	11,817,600	12,980	Sep 16 07:36 PM
Balo Andrew K	*	Sep 15	Sale	397.35	5,256	2,088,490	35,567	Sep 16 04:44 PM
FOLETTA MARK G	Director	Sep 14	Sale	394.14	1,000	394,136	15,202	Sep 16 04:44 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Sep 10	Sale	400.59	12,193	4,884,343	44,124	Sep 11 06:57 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Sep 10	Sale	400.62	2,102	842,104	17,753	Sep 11 06:59 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Sep 09	Sale	398.30	2,226	886,620	19,855	Sep 11 06:59 PM
Sylvain Jereme M	SVP, Finance & CAO	Sep 09	Sale	398.30	289	115,109	12,532	Sep 11 06:59 PM
Balo Andrew K	*	Sep 09	Sale	398.30	4,580	1,824,223	40,823	Sep 11 06:57 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Sep 09	Sale	398.30	12,886	5,132,520	56,317	Sep 11 06:57 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Sep 09	Sale	398.30	4,699	1,871,621	46,812	Sep 11 06:58 PM
Leach Jacob Steven	EVP Chief Technology Officer	Sep 09	Sale	398.30	3,860	1,537,446	103,548	Sep 11 06:58 PM
Abbey Donald	EVP Quality and Regulatory Aff	Sep 09	Sale	394.43	9,739	3,841,392	50,202	Sep 11 06:57 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Sep 09	Sale	398.30	2,444	973,450	25,732	Sep 11 06:58 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 09	Sale	398.30	4,580	1,824,223	68,297	Sep 11 06:58 PM
SAYER KEVIN R	President, CEO and Chairman	Sep 09	Sale	398.30	9,965	3,969,079	142,577	Sep 11 06:59 PM
Abbey Donald	EVP Quality and Regulatory Aff	Aug 24	Sale	424.66	9,766	4,147,227	59,941	Aug 26 07:03 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Aug 24	Sale	427.22	1,530	653,642	1,530	Aug 26 07:03 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Aug 24	Sale	427.24	1,531	654,107	72,877	Aug 26 07:04 PM
Sylvain Jereme M	SVP, Finance & CAO	Aug 24	Sale	427.41	600	256,446	12,817	Aug 26 07:04 PM
ALTMAN STEVEN R	Director	Aug 10	Sale	435.05	2,000	870,093	42,980	Aug 12 05:11 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Aug 10	Sale	439.31	500	219,655	28,176	Aug 12 05:11 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Aug 10	Sale	439.31	400	175,724	22,041	Aug 12 05:11 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jul 23	Sale	427.31	1,531	654,213	74,408	Jul 27 05:53 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jul 23	Sale	427.29	1,531	654,188	3,060	Jul 27 05:53 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Jul 10	Sale	439.33	400	175,732	22,441	Jul 14 04:27 PM
ALTMAN STEVEN R	Director	Jul 10	Sale	437.50	2,000	874,993	44,980	Jul 14 04:27 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jul 09	Sale	435.80	500	217,900	28,676	Jul 10 05:13 PM
SAYER KEVIN R	President, CEO and Chairman	Jul 06	Sale	420.94	6,000	2,525,662	152,542	Jul 08 07:01 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jun 23	Sale	409.41	1,531	626,807	4,591	Jun 25 06:45 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jun 23	Sale	409.37	1,531	626,750	75,939	Jun 25 06:45 PM
Balo Andrew K	*	Jun 15	Sale	366.47	6,522	2,390,096	45,376	Jun 17 06:01 PM
AUGUSTINOS NICHOLAS	Director	Jun 15	Sale	366.65	1,875	687,463	15,717	Jun 17 06:01 PM
Leach Jacob Steven	EVP Chief Technology Officer	Jun 11	Sale	376.76	19,129	7,207,029	107,369	Jun 15 06:00 PM
ALTMAN STEVEN R	Director	Jun 10	Sale	385.71	2,000	771,413	46,980	Jun 12 06:54 PM
KAHN BARBARA	Director	Jun 10	Sale	380.71	7,000	2,665,001	6,879	Jun 12 06:54 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Jun 10	Sale	385.22	400	154,088	22,841	Jun 12 06:54 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jun 09	Sale	375.36	500	187,680	29,176	Jun 10 05:50 PM
SAYER KEVIN R	President, CEO and Chairman	Jun 01	Sale	376.57	6,000	2,259,400	158,542	Jun 02 04:43 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	May 26	Sale	408.49	1,474	602,114	23,241	May 28 06:47 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	May 22	Sale	396.74	1,531	607,409	77,470	May 27 06:06 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	May 22	Sale	396.74	1,531	607,409	6,122	May 27 05:56 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	May 11	Sale	404.05	400	161,620	24,715	May 13 06:30 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	May 11	Sale	404.05	500	202,025	29,676	May 13 06:16 PM
SAYER KEVIN R	President, CEO and Chairman	May 04	Sale	344.63	6,000	2,067,761	164,542	May 06 08:34 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Apr 23	Sale	318.57	1,530	487,412	7,653	Apr 27 05:00 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Apr 23	Sale	318.57	1,531	487,731	79,001	Apr 27 04:51 PM
Balo Andrew K	*	Apr 15	Sale	283.39	6,690	1,895,895	51,898	Apr 17 06:04 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Apr 13	Sale	279.88	400	111,952	25,394	Apr 15 05:18 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Apr 09	Sale	259.95	500	129,975	30,176	Apr 13 06:44 PM
SAYER KEVIN R	President, CEO and Chairman	Apr 07	Sale	262.81	6,000	1,576,839	170,542	Apr 08 06:10 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 30	Sale	271.79	1,214	329,950	25,794	Apr 01 05:37 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 23	Sale	209.23	1,531	320,335	80,532	Mar 25 06:22 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Mar 23	Sale	209.27	1,531	320,396	9,183	Mar 25 06:10 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 12	Sale	233.55	6,353	1,483,724	69,203	Mar 13 09:17 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 11	Sale	264.78	6,208	1,643,725	75,556	Mar 13 09:17 PM
MOY JEFFREY	EVP Operations	Mar 11	Sale	264.76	6,203	1,642,289	31,397	Mar 13 09:17 PM
Sylvain Jereme M	SVP, Finance & CAO	Mar 11	Sale	264.83	613	162,340	13,417	Mar 13 09:17 PM
Leach Jacob Steven	EVP Chief Technology Officer	Mar 11	Sale	264.69	6,909	1,828,756	127,498	Mar 13 09:17 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 11	Sale	264.82	8,049	2,131,534	84,313	Mar 13 09:11 PM
Murphy Patrick Michael	*	Mar 11	Sale	264.77	4,082	1,080,794	30,676	Mar 13 09:07 PM
Balo Andrew K	*	Mar 11	Sale	264.82	8,161	2,161,231	58,588	Mar 13 09:29 PM
Abbey Donald	EVP Quality and Regulatory Aff	Mar 11	Sale	264.68	8,050	2,130,657	69,707	Mar 13 09:28 PM
ACE HEATHER S	SVP Human Resources	Mar 11	Sale	264.69	6,207	1,642,902	38,584	Mar 13 09:28 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 11	Sale	264.70	3,387	896,528	27,008	Mar 13 09:20 PM
SAYER KEVIN R	President, CEO and Chairman	Mar 11	Sale	264.82	20,374	5,395,432	190,016	Mar 13 09:17 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Mar 11	Sale	264.74	8,303	2,198,160	52,005	Mar 13 09:36 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 09	Sale	261.00	891	232,551	81,764	Mar 10 08:19 PM
SAYER KEVIN R	President, CEO and Chairman	Mar 09	Sale	269.02	6,000	1,614,099	210,390	Mar 10 07:34 PM
ACE HEATHER S	SVP Human Resources	Mar 09	Sale	269.75	7,885	2,126,955	44,791	Mar 10 08:56 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 09	Sale	261.00	439	114,579	30,395	Mar 10 08:29 PM
Murphy Patrick Michael	*	Mar 09	Sale	261.00	500	130,500	34,758	Mar 10 06:49 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 05	Option Exercise	9.80	8,927	87,485	83,551	Mar 09 05:11 PM
FOLETTA MARK G	Director	Mar 03	Sale	277.08	1,000	277,079	13,147	Mar 04 06:42 PM
MOY JEFFREY	EVP Operations	Mar 02	Sale	278.10	362	100,672	25,032	Mar 03 08:15 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Feb 24	Sale	277.75	1,532	425,507	10,714	Feb 26 04:31 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Feb 24	Sale	277.81	1,531	425,323	74,624	Feb 26 04:24 PM
Leach Jacob Steven	EVP Chief Technology Officer	Feb 18	Option Exercise	9.78	11,458	112,059	122,563	Feb 19 07:53 PM
MOY JEFFREY	EVP Operations	Feb 18	Sale	286.91	6,599	1,893,318	25,220	Feb 20 06:23 PM
Collins Richard Alexander	Director	Feb 18	Sale	284.40	4,000	1,137,600	5,304	Feb 20 06:17 PM
AUGUSTINOS NICHOLAS	Director	Feb 14	Sale	283.80	1,812	514,246	3,230	Feb 18 06:58 PM
Murphy Patrick Michael	SVP, Legal Affairs	Feb 10	Sale	240.59	500	120,295	26,447	Feb 11 07:53 PM
SAYER KEVIN R	President, CEO and Chairman	Feb 10	Sale	242.39	6,000	1,454,367	190,937	Feb 11 07:48 PM
FOLETTA MARK G	Director	Feb 03	Sale	237.84	1,000	237,843	14,147	Feb 05 06:04 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jan 23	Sale	234.34	1,532	359,003	12,246	Jan 27 05:13 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jan 23	Sale	234.32	1,532	358,971	76,155	Jan 27 05:06 PM
SAYER KEVIN R	President, CEO and Chairman	Jan 13	Sale	230.62	6,000	1,383,710	196,937	Jan 15 04:48 PM
Murphy Patrick Michael	SVP, Legal Affairs	Jan 09	Sale	235.01	500	117,505	26,947	Jan 10 08:03 PM
FOLETTA MARK G	Director	Jan 03	Sale	218.05	1,000	218,053	15,147	Jan 07 08:49 PM
SKYLER JAY S	Director	Jan 03	Sale	217.85	25,806	5,621,816	30,417	Jan 07 08:50 PM
ALTMAN STEVEN R	Director	Jan 02	Sale	218.33	2,500	545,834	46,304	Jan 06 09:05 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Dec 23	Sale	213.17	1,532	326,576	77,687	Dec 23 07:42 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Dec 23	Sale	213.02	1,533	326,558	13,778	Dec 23 07:42 PM
AUGUSTINOS NICHOLAS	Director	Dec 16	Sale	206.14	1,812	373,526	5,042	Dec 16 09:17 PM
KAHN BARBARA	Director	Dec 12	Sale	205.14	9,000	1,846,222	11,266	Dec 16 09:16 PM
Murphy Patrick Michael	SVP, Legal Affairs	Dec 09	Sale	224.42	5,518	1,238,346	27,447	Dec 10 08:42 PM
FOLETTA MARK G	Director	Dec 03	Sale	227.59	1,000	227,593	16,147	Dec 05 04:22 PM
SAYER KEVIN R	President, CEO and Chairman	Dec 02	Sale	221.37	10,000	2,213,684	202,937	Dec 04 08:04 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Nov 22	Sale	217.56	1,532	333,300	79,219	Nov 25 07:42 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience